Your browser doesn't support javascript.
loading
Expression and significance of calreticulin in human osteosarcoma.
Zhang, Xu-Hua; Zhang, Yue; Xie, Wen-Peng; Sun, De-Sheng; Zhang, Yong-Kui; Hao, Yan-Ke; Tan, Guo-Qing.
Afiliação
  • Zhang XH; Department of Clinical Chemistry, The Second Hospital of Shandong University, Jinan, Shandong, China.
  • Zhang Y; Department of Clinical Chemistry, The Second Hospital of Shandong University, Jinan, Shandong, China.
  • Xie WP; Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Sun DS; Department of Clinical Chemistry, The Second Hospital of Shandong University, Jinan, Shandong, China.
  • Zhang YK; Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Hao YK; Department of Orthopedics, The People's Hospital of Penglai City, Penglai, Shandong, China.
  • Tan GQ; Department of Orthopedics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Cancer Biomark ; 18(4): 405-411, 2017.
Article em En | MEDLINE | ID: mdl-28106543
BACKGROUND: As one of the endoplasmic reticulum proteins, calreticulin (CRT) plays a significant role in the body, and it has been used by many researchers as a target for anti-tumor therapy. OBJECTIVE: The main purpose of the present study was to study expression of CRT of human osteosarcoma, and analyze the distinctions between normal and tumor tissues, pre- and post-chemotherapy patients, and metastatic and non-metastatic tumors in respect to this expression. METHODS: Immunofluorescent staining was used in order to investigate expression of CRT in diverse tissues. The whole RNA and proteins were extracted from the crushed tissues and used in the reverse transcription polymerase chain reaction (RT-PCR) and western blotting analysis. RESULTS: The present study detected expression of CRT in patients with osteosarcoma and revealed a higher expression level in normal tissues surrounding tumors compared with tumor tissues, in the non-metastasis group compared with the metastasis group, and in the chemotherapy group compared with the non-chemotherapy group. CONCLUSIONS: These results could indicate a brand-new biological marker which may be applied to estimate the features and prognosis of osteosarcoma.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Prognóstico / Biomarcadores Tumorais / Osteossarcoma / Calreticulina Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biomark Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Prognóstico / Biomarcadores Tumorais / Osteossarcoma / Calreticulina Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biomark Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China